Letter to Editor
BibTex RIS Cite

Year 2021, Volume: 3 Issue: 1, 10 - 11, 23.04.2021

Halit Oğuz , Ömer Yılmaz

Abstract

References

  • Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.
  • Dadhich A, Nilesh K, Patil R, Saluja H. Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Rep. 2021;14(1).
  • Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002-4.
  • Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;10(4)
  • Mtibaa L, Halwani C, Tbini M, et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020;27:64-7.

Increasing cases of Orbital Mucormycosis in recent years

Year 2021, Volume: 3 Issue: 1, 10 - 11, 23.04.2021

Halit Oğuz , Ömer Yılmaz

Abstract

Mucormycosis is a uncommon but aggressive and lethal fungal infection, which can rapidly spread especially in immunosuppressed patients. In recent years, there has been a serious increase in the number of orbital mucormycosis cases and publications. Mucormycosis prevalence in India is approximately 70 times more than the prevalence in developed countries. Diabetes mellitus, immunosuppression and trauma are major risk factors. Recently, COVİD-19 disease is common. COVID-19 infection and its treatment lead to immunosuppression, this has made patients vulnerable to secondary infections, including mucormycosis. Ophthalmologists should be aware of the possible vision threatening complications.

Keywords

mucormycosis covid19 pandemic ocular infection

References

  • Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.
  • Dadhich A, Nilesh K, Patil R, Saluja H. Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Rep. 2021;14(1).
  • Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002-4.
  • Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;10(4)
  • Mtibaa L, Halwani C, Tbini M, et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020;27:64-7.
There are 5 citations in total.

Details

Primary Language English
Subjects Ophthalmology
Journal Section Letter to The Editor
Authors

Halit Oğuz 0000-0002-0983-5878

Ömer Yılmaz 0000-0001-5571-3735

Publication Date April 23, 2021
Acceptance Date June 8, 2021
Published in Issue Year 2021 Volume: 3 Issue: 1

Cite

APA Oğuz, H., & Yılmaz, Ö. (2021). Increasing cases of Orbital Mucormycosis in recent years. Clinical and Experimental Ocular Trauma and Infection, 3(1), 10-11.
AMA Oğuz H, Yılmaz Ö. Increasing cases of Orbital Mucormycosis in recent years. CEOTI. April 2021;3(1):10-11.
Chicago Oğuz, Halit, and Ömer Yılmaz. “Increasing Cases of Orbital Mucormycosis in Recent Years”. Clinical and Experimental Ocular Trauma and Infection 3, no. 1 (April 2021): 10-11.
EndNote Oğuz H, Yılmaz Ö (April 1, 2021) Increasing cases of Orbital Mucormycosis in recent years. Clinical and Experimental Ocular Trauma and Infection 3 1 10–11.
IEEE H. Oğuz and Ö. Yılmaz, “Increasing cases of Orbital Mucormycosis in recent years”, CEOTI, vol. 3, no. 1, pp. 10–11, 2021.
ISNAD Oğuz, Halit - Yılmaz, Ömer. “Increasing Cases of Orbital Mucormycosis in Recent Years”. Clinical and Experimental Ocular Trauma and Infection 3/1 (April 2021), 10-11.
JAMA Oğuz H, Yılmaz Ö. Increasing cases of Orbital Mucormycosis in recent years. CEOTI. 2021;3:10–11.
MLA Oğuz, Halit and Ömer Yılmaz. “Increasing Cases of Orbital Mucormycosis in Recent Years”. Clinical and Experimental Ocular Trauma and Infection, vol. 3, no. 1, 2021, pp. 10-11.
Vancouver Oğuz H, Yılmaz Ö. Increasing cases of Orbital Mucormycosis in recent years. CEOTI. 2021;3(1):10-1.
 Download Cover Image

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License(CC BY-NC-SA 4.0)